Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia

被引：0
|
作者：
Rikke Hebo Larsen
Lisa Lyngsie Hjalgrim
Kathrine Grell
Kim Kristensen
Line Gerner Pedersen
Emilie Damgaard Brünner
Bodil Als-Nielsen
Kjeld Schmiegelow
Jacob Nersting
机构：
[1] University Hospital Rigshospitalet,Department of Pediatrics and Adolescent Medicine
[2] University of Copenhagen,Section of Biostatistics, Department of Public Health
[3] Novo Nordisk,Discovery and Development PKPD
[4] University of Copenhagen,Institute of Clinical Medicine, Faculty of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2020年 / 86卷
关键词：
Childhood acute lymphoblastic leukemia; Leukemia; Cancer; Mercaptopurine; Pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：25 / 32
页数：7
相关论文
共 50 条
  • [1] Pharmacokinetics of tablet and liquid formulations of oral 6-mercaptopurine in children with acute lymphoblastic leukemia
    Larsen, Rikke Hebo
    Hjalgrim, Lisa Lyngsie
    Grell, Kathrine
    Kristensen, Kim
    Pedersen, Line Gerner
    Brunner, Emilie Damgaard
    Als-Nielsen, Bodil
    Schmiegelow, Kjeld
    Nersting, Jacob
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2020, 86 (01) : 25 - 32
  • [2] Pharmacokinetics of two 6-mercaptopurine liquid formulations in children with acute lymphoblastic leukemia
    Tolbert, Jaszianne A.
    Bai, Shasha
    Abdel-Rahman, Susan M.
    August, Keith J.
    Weir, Scott J.
    Kearns, Gregory L.
    Neville, Kathleen A.
    PEDIATRIC BLOOD & CANCER, 2017, 64 (08)
  • [3] PHARMACOKINETICS (PK) OF TWO 6-MERCAPTOPURINE (6-MP) LIQUID FORMULATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL).
    Tolbert, J. A.
    Kearns, G. L.
    Abdel-Rahman, S. M.
    Weir, S. J.
    Leeder, J. S.
    Neville, K. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S94 - S94
  • [4] Relative Oral Bioequivalence of Two 6-Mercaptopurine (6-MP) Liquid Formulations in Children with Acute Lymphoblastic Leukemia (ALL)
    Tolbert, Jaszianne A.
    August, Keith J.
    Abdel-Rahman, Susan M.
    Weir, Scott J.
    Leeder, J. Steven
    Neville, Kathleen A.
    BLOOD, 2014, 124 (21)
  • [5] PHARMACOKINETICS OF ELIMINATION OF 6-MERCAPTOPURINE IN THE URINE OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    HERMANN, T
    CHRZANOWSKA, M
    MICHALEWSKA, D
    SKIBINSKA, L
    POLISH JOURNAL OF PHARMACOLOGY AND PHARMACY, 1985, 37 (02): : 209 - 216
  • [6] DISPOSITION OF ORAL METHOTREXATE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA AND ITS RELATION TO 6-MERCAPTOPURINE PHARMACOKINETICS
    KOREN, G
    SOLH, H
    KLEIN, J
    SOLDIN, SJ
    GREENBERG, M
    MEDICAL AND PEDIATRIC ONCOLOGY, 1989, 17 (06): : 450 - 454
  • [7] FAT-BODY MASS AND PHARMACOKINETICS OF ORAL 6-MERCAPTOPURINE IN CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    ZUCCARO, P
    GUANDALINI, S
    PACIFICI, R
    PICHINI, S
    DIMARTINO, L
    GUIDUCCI, M
    GIULIANO, M
    DITULLIO, MT
    MANTOVANI, MP
    THERAPEUTIC DRUG MONITORING, 1991, 13 (01) : 37 - 41
  • [8] Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
    Alsous, Mervat
    Abu Farha, Rana
    Alefishat, Eman
    Al Omar, Suha
    Momani, Deema
    Gharabli, Alia
    McElnay, James
    Horne, Robert
    Rihani, Rawad
    PLOS ONE, 2017, 12 (09):
  • [9] INTRAINDIVIDUAL VARIATION IN 6-MERCAPTOPURINE PHARMACOKINETICS DURING ORAL-MAINTENANCE THERAPY OF CHILDREN WITH ACUTE LYMPHOBLASTIC-LEUKEMIA
    LAFOLIE, P
    HAYDER, S
    BJORK, O
    PETERSON, C
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 40 (06) : 599 - 601
  • [10] IS 6-Mercaptopurine Suspension Therapeutically Equivalent to Tablet in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy?
    De Beaumais, T. Adam
    Benchikh, A.
    Medard, Y.
    Simonin, M.
    Magreault, S.
    Tabone, M. D.
    Jacqz-Aigrain, E.
    Petit, A.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S571 - S572
12345